Press Releases - NUS Medicine

21 Jan 2025

Shorter, Smarter, Safer: Short-course antibiotics can revolutionise healthcare

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Duke-NUS Medical School have provided compelling evidence that short-course antibiotic treatments can be a game-changer in tackling ventilator-associated pneumonia (VAP), a serious infection common in critically ill patients.

15 Jan 2025

NUS Medicine study discovers potential for new colorectal cancer treatment

Colorectal cancer (CRC) is a type of cancer that begins in the colon (large intestine) or rectum, which are parts of the digestive system. It typically starts as abnormal growths called polyps that form in the lining of the colon or rectum. Over time, some of these polyps can become cancerous if left untreated. CRC is one of the most common cancers in Singapore, with an average of about 2,540 cases a year, and it is also one of the top cancers contributing to cancer mortality in Singapore. It is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases according to the reports from World Health Organization (WHO). Issues including cancer recurrence and development of drug resistance pose a significant challenge in CRC treatment, highlighting the need for new therapeutic methods.

13 Jan 2025

NUS Medicine study: Brain connectome phenotype linked to cerebrovascular disease can track cognitive decline

Researchers have uncovered novel insights into how brain function disruptions related to cerebrovascular disease (CeVD) interact with Alzheimer’s disease (AD) pathology to impact neurodegeneration and cognition in older adults. Led by Associate Professor Juan Helen Zhou, Director of the Centre for Translational Magnetic Resonance Research, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), the research team revealed a brain functional connectome phenotype that is related to multiple CeVD markers and contributes additively to cognitive decline and neurodegeneration alongside AD. The study highlights CeVD as a global disruptor of brain connectivity, reshaping our understanding of its role in dementia.

09 Jan 2025

Official Launch of Global Heat Health Information Network Southeast Asia Hub at NUS Medicine

The GHHIN Southeast Asia Hub was launched at the first GHHIN Southeast Asia Heat Health Forum, a four-day forum that will serve as a pivotal platform for fostering partnerships, advancing evidence-based policies to manage extreme heat risks effectively in the region, and enhancing the region’s collective capacity to protect lives and livelihoods.

03 Jan 2025

NUS Medicine students bring hearing care to Cambodian villagers

Students working on Project Battambang as part of NUS Medicine’s Health, Humanitarian & Leadership (HHL) Programme collaborated with audiologists from WS Audiology, a global leader in the hearing aid industry, to conduct vital health screenings that included for the first time, professional hearing assessments for villagers in Poipet, Cambodia.

19 Dec 2024

NUS Medicine researchers unveil NeuroAI-powered analytical tool for early detection and diagnosis of brain disorders

To improve our understanding of how different brain regions work together and develop better methods for analysing the complex, changing patterns of brain activity over time and space, researchers at the Yong Loo Lin School of Medicine (NUS Medicine) have unveiled a cutting-edge analytical tool designed for analysing brain dynamics, known as Brain-JEPA (Joint-Embedding Predictive Architecture).

19 Dec 2024

Bioengineered yeast microbes as targeted drug delivery systems

Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) have developed a groundbreaking way to engineer yeast (Saccharomyces cerevisiae) to create microbial communities that can perform complex tasks and self-regulate their composition in response to external signals.

13 Dec 2024

NUS Medicine's Vincenzo Sorrentino Joins EMBO Global Investigator Network to Advance Healthy Longevity Research

Research to focus on targeting the connection between mitochondria and proteostasis to extend healthspan.

19 Nov 2024

Singapore launches world’s first advanced degrees in sustainable healthcare for low-carbon healthcare future

Established by the Centre for Sustainable Medicine at the Yong Loo Lin School of Medicine, National University of Singapore, the world’s first Master’s programme in sustainable healthcare will address critical climate challenges, alongside a new Executive Fellowship for senior professionals. Applications are open today for the first batch of intake, set to begin in August 2025.